tirzepatide for long covid VisualAbstract: Once-weekly tirzepatide significantly improves weight and glycemic control in patients with with obesity and type 2 diabetes

REMOTE STUDY OPPORTUNITY• @scrippsresearch has launched a fully remote, year-long digital clinical trial to test whether the repurposed drug tirzepatide can reduce Long COVID symptoms. 🙃 Enrolling 1,000 participants who are

24.36

★★★★☆4.8 (126)

Is microdosing Zepbound (tirzepatide), a GLP‑1/GIP receptor agonist, appropriate for treating long‑COVID (post‑viral syndrome)?

26.40

★★★★★4.9 (98)

Tirzepatide confers wide range of benefits in type 1 diabetes

27.00

★★★★★5.0 (157)

We've just launched the first large, site-less (home, direct to participant) randomized trial for treatment of #LongCovid, testing tirzepatide (a GLP-1 drug) vs placebo. Please help spread the word https://t.co/9xiWw1VdiF

28.87

★★★★★4.7 (84)

Data from Eli Lilly's two phase 3 tirzepatide studies shared

20.84

★★★★★4.9 (203)

Patient-Led Research Collaborative (PLRC) and RTHM Clinic recently released the Long COVID Treatment Guide to support more informed conversations between patients and their clinicians. The guide covers over 30 different interventions. Today,

28.78

★★★★★5.0 (176)

Potential role of tirzepatide towards Covid-19 infection in diabetic patients: a perspective approach – ScienceOpen

28.90

★★★★★4.8 (132)